logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9962352 B1

PDFFull Text
Date of Patent:
May. 08, 2018

Filed:

Nov. 07, 2016

Creatine oral supplementation using creatine hydrochloride salt

Applicants:

Vireo Systems, Inc., Madison, TN (US);

Board of Regents of the University of Nebraska, Lincoln, NE (US);

Inventors:

Donald W. Miller, Winnipeg, CA;

Jonathan L. Vennerstrom, Omaha, NE (US);

Mark C. Faulkner, Madison, TN (US);

Assignees:

Vireo Systems, Inc., Madison, TN (US);

Board of Regents of the University of Nebraska, Lincoln, NE (US);

Attorney:

Bradley Arant Boult Cummings LLP

Primary Examiner:

Kevin E Weddington

Int. Cl.
CPC ...
A61K 31/195 (2006.01); A61K 31/198 (2006.01); A61K 31/661 (2006.01); A23L 2/52 (2006.01); A61K 31/185 (2006.01); A23K 20/105 (2016.01); A23K 20/142 (2016.01); A23K 50/10 (2016.01); A23L 33/10 (2016.01); A23L 33/175 (2016.01); A23K 20/10 (2016.01); A61K 9/00 (2006.01); A23P 10/40 (2016.01);
U.S. Cl.
CPC ...
A61K 31/198 (2013.01); A23K 20/10 (2016.05); A23K 20/105 (2016.05); A23K 20/142 (2016.05); A23K 50/10 (2016.05); A23L 2/52 (2013.01); A23L 33/10 (2016.08); A23L 33/175 (2016.08); A61K 9/0053 (2013.01); A61K 31/185 (2013.01); A61K 31/195 (2013.01); A61K 31/661 (2013.01); A23P 10/40 (2016.08); A23V 2002/00 (2013.01);
Abstract

The present invention is directed to an oral supplement including creatine hydrochloride, which has an aqueous solubility that is at least 15 times greater than creatine monohydrate, where the oral supplement drives significant improvements in muscle development and recovery due to its enhanced bio-availability, while causing fewer negative side effects compared to previous forms of creatine.

Find Patent Forward Citations

Miller, Donald. (2018). Creatine oral supplementation using creatine hydrochloride salt (U.S. Patent No. 9962352). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9962352

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…